SLC22A9
gene geneOn this page
Also known as OAT4FLJ23666UST3OAT7
Summary
SLC22A9 (solute carrier family 22 member 9, HGNC:16261) is a protein-coding gene on chromosome 11q12.3, encoding Organic anion transporter 7 (Q8IVM8). Sodium-independent organic anion transporter, exhibits high specificity for sulfated conjugates of xenobiotics and steroid hormones such as estrone 3-sulfate (E1S) and dehydroepiandrosterone sulfate (DHEAS).
Enables short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Located in basolateral plasma membrane. Implicated in Lynch syndrome and mismatch repair cancer syndrome.
Source: NCBI Gene 114571 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 73 total
- Druggable target: yes
- MANE Select transcript:
NM_080866
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16261 |
| Approved symbol | SLC22A9 |
| Name | solute carrier family 22 member 9 |
| Location | 11q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OAT4, FLJ23666, UST3, OAT7 |
| Ensembl gene | ENSG00000149742 |
| Ensembl biotype | protein_coding |
| OMIM | 607579 |
| Entrez | 114571 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 13 protein_coding, 1 nonsense_mediated_decay
ENST00000279178, ENST00000536333, ENST00000863020, ENST00000863021, ENST00000863022, ENST00000863023, ENST00000863024, ENST00000863025, ENST00000863026, ENST00000863027, ENST00000863028, ENST00000863029, ENST00000863030, ENST00000863031
RefSeq mRNA: 1 — MANE Select: NM_080866
NM_080866
CCDS: CCDS8043
Canonical transcript exons
ENST00000279178 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001119295 | 63373644 | 63373798 |
| ENSE00001657825 | 63409802 | 63410294 |
| ENSE00002215090 | 63369785 | 63370458 |
| ENSE00002484922 | 63371135 | 63371238 |
| ENSE00003485844 | 63373894 | 63374062 |
| ENSE00003549780 | 63406497 | 63406711 |
| ENSE00003587152 | 63408112 | 63408220 |
| ENSE00003590418 | 63382159 | 63382277 |
| ENSE00003594450 | 63375645 | 63375768 |
| ENSE00003683608 | 63408676 | 63408879 |
Expression profiles
Bgee: expression breadth broad, 43 present calls, max score 83.61.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1117 / max 38.8015, expressed in 13 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114790 | 0.1117 | 13 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 83.61 | gold quality |
| liver | UBERON:0002107 | 81.46 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 57.76 | gold quality |
| right frontal lobe | UBERON:0002810 | 56.85 | gold quality |
| sperm | CL:0000019 | 56.80 | gold quality |
| upper leg skin | UBERON:0004262 | 56.27 | silver quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 55.49 | gold quality |
| skin of hip | UBERON:0001554 | 54.86 | silver quality |
| sural nerve | UBERON:0015488 | 54.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 52.53 | gold quality |
| gall bladder | UBERON:0002110 | 51.66 | gold quality |
| frontal cortex | UBERON:0001870 | 51.22 | gold quality |
| neocortex | UBERON:0001950 | 50.96 | gold quality |
| prefrontal cortex | UBERON:0000451 | 50.71 | gold quality |
| primary visual cortex | UBERON:0002436 | 49.44 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.08 | gold quality |
| occipital lobe | UBERON:0002021 | 47.97 | gold quality |
| amygdala | UBERON:0001876 | 47.87 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 45.45 | gold quality |
| buccal mucosa cell | CL:0002336 | 45.38 | gold quality |
| temporal lobe | UBERON:0001871 | 45.04 | gold quality |
| islet of Langerhans | UBERON:0000006 | 43.99 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 43.51 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| renal medulla | UBERON:0000362 | 42.64 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| forebrain | UBERON:0001890 | 42.39 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.11 | gold quality |
| adrenal tissue | UBERON:0018303 | 42.06 | gold quality |
| mammalian vulva | UBERON:0000997 | 41.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.09 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): HNF1A
miRNA regulators (miRDB)
20 targeting SLC22A9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-4777-5P | 99.33 | 67.53 | 1148 |
| HSA-MIR-3064-5P | 99.26 | 66.13 | 1497 |
| HSA-MIR-3085-3P | 99.26 | 66.16 | 1490 |
| HSA-MIR-6504-5P | 99.26 | 65.95 | 1487 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-6838-3P | 98.40 | 65.88 | 559 |
| HSA-MIR-4733-3P | 98.35 | 65.20 | 994 |
| HSA-MIR-8078 | 98.32 | 65.73 | 361 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-449C-3P | 97.75 | 67.86 | 462 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-663B | 97.40 | 62.91 | 664 |
| HSA-MIR-4794 | 96.47 | 65.53 | 1063 |
Literature-anchored findings (GeneRIF, showing 12)
- uptake of steroid sulfates by isolated trophoblasts is mediated by OATP-B and OAT-4 suggesting a physiological role of both carrier proteins in placental uptake of fetal-derived steroid sulfates. (PMID:12409283)
- Both progesterone and activation of PKC inhibited hOAT4 activity through redistribution of the transporter from cell surface to the intracellular compartments. (PMID:17341544)
- OAT7 is the first liver-specific transporter among members of the organic anion transporters of SLC22 family. (PMID:17393504)
- The data provide a model for the concerted action of OAT1 mediating apical secretion of glutarate derivatives from proximal tubule cells (PMID:18365245)
- The regulatory single nucleotide polymorphism (SNP) of OAT4 found in the promoter region of nephrectomized patients is unlikely to influence mRNA expression or promoter activity of OAT4. (PMID:18414781)
- Review summarizes current knowledge on the functional and phenotypic consequences of genetic variation in intestinally, hepatically and renally expressed members of solute carrier family (SLC22) member 9. (PMID:18466105)
- Functional differences in steroid uptake of SLC22A9 and SLC02B1 in human placenta are reported. (PMID:18501590)
- Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid. (PMID:19371258)
- Pravastatin is the first identified OAT7 drug substrate. Substantial inter-individual variability in hepatic OAT7 expression, majorly driven by HNF4alpha, may contribute to pravastatin drug disposition and might affect response. (PMID:26239079)
- two human organic anion transporters OAT2 and OAT7 activities were assessed. (PMID:28945155)
- Large interindividual variability was noted in the hepatic expression of OAT2 (16-fold in human liver tissue and 23-fold in hepatocytes). OAT7, on the other hand, showed less interindividual variability (4-fold) in the livers, but high variability for the hepatocyte lots (27-fold). A significant positive correlation in OAT2 and OAT7 expression was observed, but expression levels were neither associated with age nor sex. (PMID:29906129)
- The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans. (PMID:33013684)
Cross-species orthologs
60 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc22a4 | ENSDARG00000005335 |
| danio_rerio | oatx | ENSDARG00000019713 |
| danio_rerio | si:dkey-166k12.1 | ENSDARG00000054690 |
| danio_rerio | slc22a15 | ENSDARG00000055445 |
| danio_rerio | si:dkey-119m7.4 | ENSDARG00000071049 |
| danio_rerio | si:dkey-119m7.8 | ENSDARG00000096654 |
| mus_musculus | Slc22a19 | ENSMUSG00000024757 |
| mus_musculus | Slc22a30 | ENSMUSG00000052562 |
| mus_musculus | Slc22a26 | ENSMUSG00000053303 |
| mus_musculus | Slc22a28 | ENSMUSG00000063590 |
| mus_musculus | Slc22a27 | ENSMUSG00000067656 |
| mus_musculus | Slc22a29 | ENSMUSG00000075044 |
| rattus_norvegicus | Slc22a25 | ENSRNOG00000017964 |
| rattus_norvegicus | UST4r | ENSRNOG00000049826 |
| rattus_norvegicus | AABR07006120.1 | ENSRNOG00000056396 |
| rattus_norvegicus | Ust5r | ENSRNOG00000061890 |
| drosophila_melanogaster | Orct | FBGN0019952 |
| drosophila_melanogaster | CG15221 | FBGN0030331 |
| drosophila_melanogaster | Balat | FBGN0033778 |
| drosophila_melanogaster | CG4630 | FBGN0033809 |
| drosophila_melanogaster | CG5592 | FBGN0035645 |
| drosophila_melanogaster | CG10486 | FBGN0035647 |
| drosophila_melanogaster | SLC22A | FBGN0037140 |
| drosophila_melanogaster | CG7458 | FBGN0037144 |
| drosophila_melanogaster | CG14691 | FBGN0037829 |
| drosophila_melanogaster | CG14855 | FBGN0038260 |
| drosophila_melanogaster | CG14856 | FBGN0038261 |
| drosophila_melanogaster | CG14857 | FBGN0038262 |
| drosophila_melanogaster | CG12783 | FBGN0038448 |
| drosophila_melanogaster | CG7333 | FBGN0038715 |
| drosophila_melanogaster | CG7342 | FBGN0038716 |
| drosophila_melanogaster | CG17751 | FBGN0038717 |
| drosophila_melanogaster | CG17752 | FBGN0038718 |
| drosophila_melanogaster | CG16727 | FBGN0038719 |
| drosophila_melanogaster | CG6231 | FBGN0038720 |
| drosophila_melanogaster | CG4465 | FBGN0038750 |
| drosophila_melanogaster | CG4462 | FBGN0038752 |
| drosophila_melanogaster | CG4459 | FBGN0038753 |
| drosophila_melanogaster | CG6356 | FBGN0039178 |
| drosophila_melanogaster | CG3690 | FBGN0040350 |
| drosophila_melanogaster | CG31103 | FBGN0051103 |
| drosophila_melanogaster | CG31106 | FBGN0051106 |
| drosophila_melanogaster | CG31272 | FBGN0051272 |
| drosophila_melanogaster | CG33233 | FBGN0053233 |
| drosophila_melanogaster | CG33234 | FBGN0053234 |
| drosophila_melanogaster | Orct2 | FBGN0086365 |
| drosophila_melanogaster | CG42269 | FBGN0259164 |
| drosophila_melanogaster | CG44098 | FBGN0264907 |
| caenorhabditis_elegans | WBGENE00003837 | |
| caenorhabditis_elegans | oct-1 | WBGENE00003842 |
| caenorhabditis_elegans | WBGENE00003843 | |
| caenorhabditis_elegans | WBGENE00006220 | |
| caenorhabditis_elegans | WBGENE00008110 | |
| caenorhabditis_elegans | WBGENE00011456 | |
| caenorhabditis_elegans | WBGENE00014127 | |
| caenorhabditis_elegans | WBGENE00015088 | |
| caenorhabditis_elegans | WBGENE00017751 | |
| caenorhabditis_elegans | WBGENE00019408 | |
| caenorhabditis_elegans | WBGENE00020701 | |
| caenorhabditis_elegans | WBGENE00044455 |
Paralogs (22): SLC22A16 (ENSG00000004809), SLC22A17 (ENSG00000092096), SLC22A2 (ENSG00000112499), SLC22A7 (ENSG00000137204), SLC22A23 (ENSG00000137266), SLC22A14 (ENSG00000144671), SLC22A3 (ENSG00000146477), SLC22A8 (ENSG00000149452), SVOPL (ENSG00000157703), SLC22A15 (ENSG00000163393), SVOP (ENSG00000166111), SLC22A11 (ENSG00000168065), SLC22A13 (ENSG00000172940), SLC22A1 (ENSG00000175003), SLC22A10 (ENSG00000184999), SLC22A25 (ENSG00000196600), SLC22A4 (ENSG00000197208), SLC22A5 (ENSG00000197375), SLC22A24 (ENSG00000197658), SLC22A12 (ENSG00000197891), SLC22A6 (ENSG00000197901), SLC22A31 (ENSG00000259803)
Protein
Protein identifiers
Organic anion transporter 7 — Q8IVM8 (reviewed: Q8IVM8)
Alternative names: Organic anion/short-chain fatty acid exchanger, Solute carrier family 22 member 9
All UniProt accessions (1): Q8IVM8
UniProt curated annotations — full annotation on UniProt →
Function. Sodium-independent organic anion transporter, exhibits high specificity for sulfated conjugates of xenobiotics and steroid hormones such as estrone 3-sulfate (E1S) and dehydroepiandrosterone sulfate (DHEAS). Can transport the statin pravastatin and may contribute to its disposition into the hepatocytes when the function of OATPs is compromised. It is specifically activated by 3 to 5 carbons-containing short-chain fatty acids/SCFAs, including propionate (propanoate), butyrate (butanoate) and valerate (pentanoate). May operate the exchange of sulfated organic components against short-chain fatty acids/SCFAs, in particular butanoate, at the sinusoidal membrane of hepatocytes.
Subcellular location. Basolateral cell membrane.
Tissue specificity. Specifically expressed in liver (also at protein level).
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IVM8-1 | 1 | yes |
| Q8IVM8-2 | 2 |
RefSeq proteins (1): NP_543142* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011701 | MFS | Family |
| IPR020846 | MFS_dom | Domain |
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
Pfam: PF07690
Catalyzed reactions (Rhea), 6 shown:
- butanoate(out) + estrone 3-sulfate(in) = butanoate(in) + estrone 3-sulfate(out) (RHEA:72051)
- propanoate(in) + estrone 3-sulfate(out) = propanoate(out) + estrone 3-sulfate(in) (RHEA:72555)
- pentanoate(in) + estrone 3-sulfate(out) = pentanoate(out) + estrone 3-sulfate(in) (RHEA:72559)
- dehydroepiandrosterone 3-sulfate(in) + butanoate(out) = dehydroepiandrosterone 3-sulfate(out) + butanoate(in) (RHEA:72563)
- propanoate(out) + dehydroepiandrosterone 3-sulfate(in) = propanoate(in) + dehydroepiandrosterone 3-sulfate(out) (RHEA:72567)
- pentanoate(out) + dehydroepiandrosterone 3-sulfate(in) = pentanoate(in) + dehydroepiandrosterone 3-sulfate(out) (RHEA:72571)
UniProt features (37 total): topological domain 13, transmembrane region 12, glycosylation site 3, sequence variant 3, splice variant 2, sequence conflict 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IVM8-F1 | 85.56 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 39, 56, 102
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 63 (showing top):
GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_MONOCARBOXYLIC_ACID_TRANSPORT, GOBP_LIPID_LOCALIZATION, GOBP_FATTY_ACID_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_PLASMA_MEMBRANE_REGION, GOCC_BASAL_PART_OF_CELL, GOMF_LIPID_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP
GO Biological Process (6): hormone transport (GO:0009914), obsolete organic anion transport (GO:0015711), short-chain fatty acid transmembrane transport (GO:0015913), sodium-independent organic anion transport (GO:0043252), lipid transport (GO:0006869), transmembrane transport (GO:0055085)
GO Molecular Function (4): obsolete organic anion transmembrane transporter activity (GO:0008514), obsolete sodium-independent organic anion transmembrane transporter activity (GO:0015347), short-chain fatty acid transmembrane transporter activity (GO:0015636), transmembrane transporter activity (GO:0022857)
GO Cellular Component (3): basolateral plasma membrane (GO:0016323), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 3 |
| short-chain fatty acid transport | 2 |
| transmembrane transport | 2 |
| regulation of hormone levels | 1 |
| fatty acid transmembrane transport | 1 |
| lipid localization | 1 |
| cellular process | 1 |
| fatty acid transmembrane transporter activity | 1 |
| transporter activity | 1 |
| basal plasma membrane | 1 |
| plasma membrane region | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
842 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC22A9 | SLC47A2 | Q86VL8 | 762 |
| SLC22A9 | SLC47A1 | Q96FL8 | 760 |
| SLC22A9 | SLC2A9 | Q9NRM0 | 723 |
| SLC22A9 | ABCC4 | O15439 | 703 |
| SLC22A9 | SLCO2B1 | O94956 | 702 |
| SLC22A9 | SLCO1A2 | P46721 | 691 |
| SLC22A9 | SLCO4C1 | Q6ZQN7 | 682 |
| SLC22A9 | SLCO1B3 | Q9NPD5 | 658 |
| SLC22A9 | SLCO1B1 | Q9Y6L6 | 653 |
| SLC22A9 | SLC17A1 | Q14916 | 645 |
| SLC22A9 | ABCG2 | Q9UNQ0 | 621 |
| SLC22A9 | SLC17A3 | O00476 | 611 |
| SLC22A9 | SLCO4A1 | Q96BD0 | 597 |
| SLC22A9 | SLCO3A1 | Q9UIG8 | 567 |
| SLC22A9 | ABCC2 | Q92887 | 561 |
IntAct
134 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC22A9 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A9 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | SNX27 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | SHANK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGI2 | SLC22A9 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | NHERF2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | PDZK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | RHPN1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | PARD3B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PDZD7 | SLC22A9 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PTPN3 | SLC22A9 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | TIAM2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | SCRIB | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| APBA3 | SLC22A9 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | PDZRN4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | GRIP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | GOPC | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | SNTG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | SNTA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC22A9 | TJP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (366): ELOVL2 (Affinity Capture-MS), TMEM242 (Affinity Capture-MS), CAV1 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), SLC25A51 (Affinity Capture-MS), ZDHHC21 (Affinity Capture-MS), TMEM67 (Affinity Capture-MS), SLC22A5 (Affinity Capture-MS), MFSD5 (Affinity Capture-MS), C20orf24 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), MFSD12 (Affinity Capture-MS), SLC35B2 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), PIGW (Affinity Capture-MS)
ESM2 similar proteins: A0A3Q2IDB4, A0A8B7HA97, A4ZYQ5, A6NK97, G1SZD9, O35956, O57379, O88909, P22732, P23945, P43427, Q0IHM1, Q2KIV1, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R9C4, Q5RC45, Q5RCH6, Q5RET7, Q63ZE4, Q66J52, Q6DFR1, Q6NUB3, Q6NYN7, Q6PXP3, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q863Y9, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48, Q8N4F4, Q8R0S9
Diamond homologs: A0A3Q2IDB4, A0A8B7HA97, A6NK97, A6QLW8, B2GV36, G1SZD9, O34691, O35956, O57379, O75751, O88446, O88909, Q1RPP5, Q28ES4, Q2KIV1, Q3YAW7, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R540, Q5R9C4, Q5RC45, Q5RCH6, Q5RLM2, Q63ZE4, Q66J52, Q66J54, Q6A4L0, Q6NYN7, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| HNF1A | “up-regulates quantity by expression” | SLC22A9 | “transcriptional regulation” |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 51.9× | 2e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 49.4× | 2e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 49.4× | 2e-06 |
| Long-term potentiation | 5 | 43.3× | 3e-06 |
| Assembly and cell surface presentation of NMDA receptors | 9 | 41.5× | 6e-11 |
| Neurexins and neuroligins | 10 | 35.8× | 3e-11 |
| Protein-protein interactions at synapses | 6 | 29.0× | 2e-06 |
| RHOB GTPase cycle | 5 | 14.0× | 5e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 78.0× | 3e-16 |
| protein localization to synapse | 6 | 56.0× | 1e-07 |
| receptor clustering | 7 | 53.3× | 1e-08 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 42.3× | 4e-08 |
| protein-containing complex assembly | 9 | 12.5× | 3e-06 |
| cell-cell adhesion | 10 | 12.4× | 6e-07 |
| regulation of small GTPase mediated signal transduction | 5 | 8.8× | 5e-03 |
| chemical synaptic transmission | 7 | 6.6× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
73 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1325 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:63370456:GAG:G | donor_gain | 1.0000 |
| 11:63370457:AGGT:A | donor_loss | 1.0000 |
| 11:63370459:G:GG | donor_gain | 1.0000 |
| 11:63370459:GTAA:G | donor_loss | 1.0000 |
| 11:63370460:T:A | donor_loss | 1.0000 |
| 11:63373794:GTTAA:G | donor_gain | 1.0000 |
| 11:63373795:T:G | donor_gain | 1.0000 |
| 11:63373799:G:GG | donor_gain | 1.0000 |
| 11:63373892:A:AG | acceptor_gain | 1.0000 |
| 11:63373893:G:GG | acceptor_gain | 1.0000 |
| 11:63373893:GTA:G | acceptor_gain | 1.0000 |
| 11:63408880:G:GG | donor_gain | 1.0000 |
| 11:63371133:A:AG | acceptor_gain | 0.9900 |
| 11:63371133:AGT:A | acceptor_gain | 0.9900 |
| 11:63371133:AGTG:A | acceptor_gain | 0.9900 |
| 11:63371134:G:GG | acceptor_gain | 0.9900 |
| 11:63371134:GT:G | acceptor_gain | 0.9900 |
| 11:63371134:GTG:G | acceptor_gain | 0.9900 |
| 11:63371134:GTGG:G | acceptor_gain | 0.9900 |
| 11:63372023:C:G | donor_gain | 0.9900 |
| 11:63373090:G:GG | donor_gain | 0.9900 |
| 11:63373795:T:TG | donor_gain | 0.9900 |
| 11:63373893:GT:G | acceptor_gain | 0.9900 |
| 11:63374156:A:AG | acceptor_gain | 0.9900 |
| 11:63375638:T:TA | acceptor_gain | 0.9900 |
| 11:63408198:G:GT | donor_gain | 0.9900 |
| 11:63408661:T:A | acceptor_gain | 0.9900 |
| 11:63408672:AAAG:A | acceptor_gain | 0.9900 |
| 11:63408773:T:TA | acceptor_gain | 0.9900 |
| 11:63408875:AATGA:A | donor_gain | 0.9900 |
AlphaMissense
3646 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:63370063:T:C | F3L | 0.967 |
| 11:63370065:T:A | F3L | 0.967 |
| 11:63370065:T:G | F3L | 0.967 |
| 11:63408676:G:C | R466S | 0.963 |
| 11:63408676:G:T | R466S | 0.963 |
| 11:63370201:T:A | C49S | 0.956 |
| 11:63370202:G:C | C49S | 0.956 |
| 11:63370327:T:C | F91L | 0.955 |
| 11:63370329:T:A | F91L | 0.955 |
| 11:63370329:T:G | F91L | 0.955 |
| 11:63370174:T:C | F40L | 0.948 |
| 11:63370176:C:A | F40L | 0.948 |
| 11:63370176:C:G | F40L | 0.948 |
| 11:63406648:A:C | S409R | 0.947 |
| 11:63406650:C:A | S409R | 0.947 |
| 11:63406650:C:G | S409R | 0.947 |
| 11:63371137:G:C | W135C | 0.945 |
| 11:63371137:G:T | W135C | 0.945 |
| 11:63406583:G:A | G387D | 0.945 |
| 11:63408717:C:A | A480E | 0.945 |
| 11:63373653:A:C | R172S | 0.943 |
| 11:63373653:A:T | R172S | 0.943 |
| 11:63375710:T:C | L299P | 0.943 |
| 11:63408147:G:C | G442R | 0.943 |
| 11:63370064:T:G | F3C | 0.941 |
| 11:63373756:G:T | G207W | 0.941 |
| 11:63373902:T:A | W224R | 0.940 |
| 11:63373902:T:C | W224R | 0.940 |
| 11:63406582:G:C | G387R | 0.939 |
| 11:63408148:G:A | G442D | 0.936 |
dbSNP variants (sampled 300 via entrez): RS1000017730 (11:63386402 A>G), RS1000018220 (11:63403064 A>G), RS1000043784 (11:63393510 A>G), RS1000074203 (11:63399155 A>C), RS1000090401 (11:63409040 C>A), RS1000140416 (11:63381295 C>T), RS1000157045 (11:63396928 T>A), RS1000452814 (11:63394413 G>A,T), RS1000615665 (11:63385116 T>TTTG,TTTGTTGTTGTTGTTG), RS1000722113 (11:63384035 G>A), RS1000789204 (11:63391277 A>G), RS1001005930 (11:63404845 G>C), RS1001095715 (11:63407782 C>T), RS1001145193 (11:63384309 C>A,G), RS1001147594 (11:63368468 A>G)
Disease associations
OMIM: gene MIM:607579 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001519_1 | Economic and political preferences | 3.000000e-06 |
| GCST002925_7 | Sex hormone levels | 8.000000e-12 |
| GCST007428_1 | Thyroxine levels | 4.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004827 | economic and social preference |
| EFO:0004730 | hormone measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2073721 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Organic anion transporters (OATs)
CTD chemical–gene interactions
48 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression | 3 |
| Aflatoxin B1 | decreases expression, decreases methylation, affects expression | 3 |
| estrone sulfate | decreases reaction, increases uptake, increases import | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| Probenecid | increases import, increases uptake, decreases activity, decreases reaction | 2 |
| OTX015 | decreases expression | 1 |
| methyleugenol | decreases expression | 1 |
| senecionine | decreases expression | 1 |
| senkirkine | decreases expression | 1 |
| heliotrine | decreases expression | 1 |
| 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate | decreases activity | 1 |
| pranlukast | decreases reaction, increases uptake | 1 |
| losartan carboxylic acid | decreases reaction, increases uptake | 1 |
| candesartan cilexetil | decreases reaction, increases uptake | 1 |
| candesartan | decreases reaction, increases uptake | 1 |
| Valsartan | decreases reaction, increases uptake | 1 |
| Rosiglitazone | decreases expression | 1 |
| Acetaminophen | decreases activity | 1 |
| Anions | increases uptake, decreases reaction | 1 |
| Aspirin | decreases activity | 1 |
| Diclofenac | decreases activity | 1 |
| Estradiol | decreases expression | 1 |
| Ibuprofen | decreases activity, increases uptake | 1 |
| Indomethacin | decreases activity, increases uptake | 1 |
| Ketoprofen | decreases activity, increases uptake | 1 |
| Mefenamic Acid | decreases activity | 1 |
| Naproxen | decreases activity | 1 |
| Phenacetin | decreases activity | 1 |
| Phenobarbital | affects expression | 1 |
ChEMBL screening assays
14 unique, capped per target: 14 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2075905 | Functional | TP_TRANSPORTER: inhibition of carnitine uptake by Carnitine-related compound-9A at 20uM in Xenopus laevis oocytes | Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. — J Biol Chem |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4SE | HuH7-SLC22A9-KO-c4 | Cancer cell line | Male |
| CVCL_D4SF | HuH7-SLC22A9-KO-c5 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.